Lightship
Decentralized clinical trials
- 21-100 employees
- Healthcare
- B2B
- Science
- MedTech
- El Segundo, CA
Jump to section
Company mission
To redefine clinical trials, providing hope for all.
26% employee growth in 12 months
Our take
Clinical trials have historically been limited by factors like attendance and testing times. Turnaround can be slow, overheads can get costly, and those who don’t have the ability or time to meet appointments go unrepresented in medical developments. Lightship is hoping to redefine clinical trials with its end-to-end collaborative solution that offers at-home participation, making trials more accessible, and their results more representative.
With FDA regulations fairly recently updated to account for at-home trial participation, Lightship's arrival has been welcomed by the industry. The task of producing sound and accurate results outside of the lab is a tough one, so the company's efforts will certainly be valuable to this new clinical trial landscape.
The company is well-funded and has strategically partnered with eClinical platform Castor to accelerate its capabilities. With an increasing focus on making trial participants more diverse, and people now acclimatised to virtual engagement, its solution is promising and has the potential to yield vital clinical results.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Disability: Short and long-term disability
- Holidays: Paid holidays and bereavemenr
- Investing in you: 401(k) matching
- Life insurance: Life insurance and more!
- Healthcare: Top healthcare for you and your family
- Work from home: A home office stipend
- Paid time off: Unlimited paid time off (PTO)
- Parental leave: Generous paid parental leave
Funding (last 2 of 3 rounds)
Feb 2024
$135.6m
LATE VC
Oct 2021
$40m
LATE VC
Total funding: $195.6m
This company has top investors
Leadership
David MacMurchy
(CEO)David has been the CEO of Lightship since 2020. Prior to this, they were the Executive VP of Europe, Asia Pacific and Africa at PRA Health Sciences, a Partner, Consumer products, Retail and Life Science Leader and Head of Life Sciences at EY, and a Director of EMEA and VP at IMS Health.
Michael Shipton
(CCO)Previously the CCO of Profound Research and Science 37. They were also an Executive Management Leader at Life Sciens and Technology and also spent 4 years at Syneos Health in various VP roles.
Darcy Forman
(COO)Previously founded Centricity Clinical where they served as the Presiedent for 5 years. Prior to that, they spent over 4 years at Science 37 as a VP of Clinical Operations, Senand Chief Delivery Officer.
Alongside Lightship, they are the Founder and CEO of ExecRx and Executive Director at i-Cubed. They have also spent 16 years at Duke University, currently serving as a Distinguished Professor. Previously, they spent over 10 years at Duke Clinical Research Institute, in various roles including Head of Pediatrics.